Dopamine on top of standard treatment for patients with exacerbation of Heart Failure, at home situatio
- Conditions
- exacerbation of Heart Failure treated at homeMedDRA version: 13.1Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 13.1Level: LLTClassification code 10019284Term: Heart failure, congestiveSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 13.1Level: LLTClassification code 10024106Term: Left heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 13.1Level: LLTClassification code 10064082Term: Heart failure NYHA class IVSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 13.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 13.1Level: LLTClassification code 10064653Term: Acute decompensated heart failureSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Registration Number
- EUCTR2011-002236-92-NL
- Lead Sponsor
- Maatschap cardiologie Isala klinieken Zwolle
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 110
Exacerbation heart failure with NYHA class III-IV
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 80
•Cardiogenic shock
•Tachycardia, heart rate > 100 bpm
•Indication for hospitalization
•Severe aortic valve stenosis
•Severe hepatic or renal disease
•Patients with acute coronary syndromes
•Previous participation in the study
•Life expectancy of < 1 year
•Absolute contra indication for the use of Dopamine
•Women of child-bearing potential
•Unable to provide informed consent
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method